webinar register page

Webinar banner
ARC Talks Webinar: Living with AL amyloidosis: Treatment Approaches
In this webinar Dr. Tuchman will provide an in-depth overview of AL amyloidosis, a review of the multi-faceted approach to treatment options for newly diagnosed, relapsed and refractory disease patients. This session provides attendees a glimpse into what the future treatment options looks like for patients including clinical trials options. Following Dr. Tuchman’s presentation there will be an audience question and answer session.


Webinar logo
* Required information
ARC TALKS is brought to you by the Amyloidosis Research Consortium, and support for this program is provided by: Ionis Pharmaceuticals, Janssen Pharmaceuticals, Alnylam Pharmaceuticals, Pfizer Inc. and Alexion AstraZeneca Rare Diseases.


Sascha Tuchman, MD, MHS
Associate Professor; Director, UNC Multiple Myeloma and Amyloidosis Program @UNC Health
Dr. Tuchman is an expert in managing patients with multiple myeloma, amyloidosis, and other plasma cell disorders. His clinical research focuses on treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems; developing novel drugs for treating all patients with multiple myeloma; and optimizing management for amyloidosis. He is a member of international working groups that formulate guidelines for treating these disorders.